KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹65 Cr | ₹55 Cr | ₹42 Cr | ₹67 Cr | ₹63 Cr |
What is the latest Total Non-Current Liabilities ratio of KERALA AYURVEDA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹65 Cr |
Mar2023 | ₹55 Cr |
Mar2022 | ₹42 Cr |
Mar2021 | ₹67 Cr |
Mar2020 | ₹63 Cr |
How is Total Non-Current Liabilities of KERALA AYURVEDA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹65 Cr | 19.29 | |
Mar2023 | ₹55 Cr | 30.65 | |
Mar2022 | ₹42 Cr | -37.36 | |
Mar2021 | ₹67 Cr | 6.55 | |
Mar2020 | ₹63 Cr | - |
Compare Total Non-Current Liabilities of peers of KERALA AYURVEDA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KERALA AYURVEDA | ₹501.8 Cr | 2.1% | 19.1% | 43.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | 0.2% | -8.3% | 15.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -1.9% | 8.6% | 55.9% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -1.3% | -5.5% | -0.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -0.5% | -4.2% | 19.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.7% | 5.8% | 6.1% | Stock Analytics |
KERALA AYURVEDA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KERALA AYURVEDA | 2.1% |
19.1% |
43.7% |
SENSEX | -0.3% |
1.5% |
8% |
You may also like the below Video Courses